New Horizons in Antimalarial Drug Discovery

Malaria remains a significant global health challenge, with millions of people affected and thousands of deaths each year. New Horizons in Antimalarial Drug Discovery: Identifying and Validating Drug Targets against FP3 offers a comprehensive overview of the latest developments in the search for effective antimalarial drugs. This book focuses on the identification and validation of drug targets against FP3, a critical enzyme in the survival and replication of the malaria parasite. With contributions from leading experts in the field, readers will gain valuable insights into cutting-edge techniques and strategies for drug discovery. This book is a must-read for researchers, clinicians, and policymakers who are committed to improving global health by combating malaria.